eNAMPT is a novel therapeutic target for mitigation of coronary microvascular disease in type 2 diabetes
2024 · Diabetologia · 6 citations
https://doi.org/10.1007/s00125-024-06201-9
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
1
Papers
25
Citations
1
h-index
1
i10-index
Makiko Watanabe is an academic researcher from The University of Osaka. The author has contributed to research in topics: Viral Infections and Immunology Research & Virology and Viral Diseases & Animal Virus Infections Studies. The author has an h-index of 1, co-authored 1 publications.
Click to start Chat